Supha Pharmachem Ltd Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

0.42 +0.02 (5.00%)Updated : 16 Apr 2026

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Operating Expense	406.37	4,008.46	502.52	503.16
Net Income After Taxes	2.13	32.73	5.43	1.08
Income Availableto Com Incl Extra Ord	2.13	32.73	5.43	1.08
Costof Revenue Total	398.14	4,001.38	493.86	498.47
Gross Profit	7.12	40.33	15.98	6.32
Interest Inc( Exp) Net- Non- Op Total	5.51	17.21	0.08	-0.11
Total Adjustmentsto Net Income	0.00	-	-	-
Diluted Weighted Average Shares	57.77	57.77	57.77	57.77
Diluted Net Income	2.13	32.73	5.43	1.08
Provisionfor Income Taxes	2.25	17.72	1.97	0.45
Depreciation/ Amortization	0.04	0.06	0.15	0.07
period Type	-	-	-	-
Net Income Before Extra Items	2.13	32.73	5.43	1.08
Total Revenue	405.25	4,041.71	509.84	504.79
Operating Income	-1.12	33.25	7.32	1.63
Net Income	2.13	32.73	5.43	1.08
period Length	12.00	12.00	12.00	12.00
Revenue	405.25	4,041.71	509.84	504.79
Income Availableto Com Excl Extra Ord	2.13	32.73	5.43	1.08
Selling/ General/ Admin Expenses Total	8.20	6.99	0.98	0.53
Net Income Before Taxes	4.38	50.45	7.40	1.53
Diluted Normalized EPS	0.04	0.57	0.09	0.02
Diluted EPS Excluding Extra Ord Items	0.04	0.57	0.09	0.02
Other Operating Expenses Total	-	0.04	7.53	4.08
Unusual Expense( Income)	-	0.00	0.00	-
Other Net	-	-	0.00	-